Flu season is here, and the stakes are especially high for patients with autoimmune diseases. Rheumatologists Cassandra Calabrese, DO, and Leonard Calabrese, DO, address common patient concerns about the influenza vaccine and share best practices for maximizing vaccination coverage.
Rheumatic Immune-Related Adverse Events from Checkpoint Inhibitor Therapy: Update
A common occurrence in the age of cancer immunotherapy, immune-related adverse events require multidisciplinary collaboration for investigation and optimal management. Drs. Cassandra and Leonard Calabrese discuss the ever-evolving field and the need for continuing education.
Immunodeficiency Diseases and the Rheumatologist: It’s Not Just About Infection
Primary immunodeficiency disorders (PID) have a growing spectrum of noninfectious complications. Vasculitis is one. Here’s what rheumatologists should take away from recent research.
Checkpoint Inhibitor Therapy for Patients with Immune-Mediated Inflammatory Diseases (Video)
Checkpoint inhibitor therapy for cancer holds great potential for durable response rates, but immune-related adverse events may be its Achilles’ heel.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Wherefore Art Thou, Empathy?
A leading rheumatologist defines empathy and describes the process of losing it during medical training.
Etiquette-Based Medicine: Complement or Affront to Evidence-Based Medicine?
A leading rheumatologist discusses communication-based empathy techniques and why physicians should ‘fake it until you make it.’
Can We Really Teach and Learn Empathy?
The Director of the R.J. Fasenmyer Center for Clinical Immunology offers his thoughts on the teaching and learning of empathy.
Advances in Biologic Therapies for IMIDs
After two decades of using biologics for IMIDs, we now have an armamentarium, including five drugs and a number of biosimilars, that continues to grow at a record pace.
The New Frontier of Autoimmune and Autoinflammatory Diseases
By now most rheumatologists are aware that checkpoint inhibitors are capable of unleashing a wide array of autoimmune and autoinflammatory adverse events within virtually every organ system. These complications have posed new challenges to all practitioners.
MPA, GPA, EGPA, Oh My! Vasculitis CME for the Fearless Clinician
No need to fear the vasculitides with this online, on-demand, complimentary CME.